HomeCompound-BibliothekenMitochondria-Targeted Compound Library

Mitochondria-Targeted Compound Library

Kat.-Nr.L9900

Eine einzigartige Sammlung von 714 Mitochondria-Targeted Compound Library, die für High-Throughput-Screening (HTS) und High-Content-Screening (HCS) verwendet wird.

96 well plates

Passen Sie Ihre Bibliothek an:

Mitochondria-Targeted Compound Library Inhalt

Beschreibung & Vorteile

•A unique collection of 714 mitochondria-targeted compounds for high throughput screening (HTS) and high content screening (HCS);
 
•A unique collection covers various aspects of mitochondrial function, such as Mitochondrial Metabolism, ATP Synthase, Mitophagy, Reactive Oxygen Species, mitochondria-associated hexokinase, Bcl-2, etc. It also includes other promising mitochondria-targeted compounds, such as lonidamine, paclitaxel, etc;
 
•Bioactivity and safety confirmed by preclinical research and /or clinical trials. Some inhibitors have been approved by FDA;
 
•Structurally diverse, medicinally active, and cell permeable;
 
•More detailed compound information with structure, IC50, and brief introduction;
 
•High purity and quality validated by NMR and HPLC;
 
• All compounds are in stock and continuously updated.

Produktdetails

Formulierung 662 compounds pre-dissolved in 10mM DMSO, 41 compounds pre-dissolved in 10mM water, 11 compounds pre-dissolved in 2mM DMSO.
Behälter 96 Deep-Well-Platte mit Aluminiumfolie versiegelt
Stabilität 12 months -20°C in DMSO
24 months -80°C in DMSO
Versand Kühlakku oder Trockeneis

Fallstudien mit Selleck Compound-Bibliotheken

Mitochondria-Targeted Compound Library Zusammensetzung

HTS-Anlagenpartner

  • Collaborating with Seleck: Yale University | Yale Center for Molecular Discovery
  • Collaborating with Seleck: Carbone Cancer Center | University of Wisconsin-Madison
  • Collaborating with Seleck: University of Colorado Denver | CU Denver
  • Collaborating with Seleck: Leibniz-Forschungsinstitut für Molekulare Pharmakologie: Leibniz-FMP
  • Collaborating with Seleck: UCSF_University of California San Francisco
  • Collaborating with Seleck: KU | High Throughput Screening Laboratory
  • Collaborating with Seleck: CIBIO
  • Collaborating with Seleck: Perelman school of medicine | University of Pennsylvania